Artes Biotechnology

Artes Biotechnology is a privately held, revenue-generating CDMO and technology provider founded in 2000 and based in Langenselbold, Germany. The company's core business is offering end-to-end microbial process development and non-GMP manufacturing services, complemented by a unique licensing model for its portfolio of pre-developed, 'ready-to-use' processes. This dual approach of custom services and off-the-shelf technology transfer positions Artes as a flexible partner for accelerating the development of recombinant protein products, with a proven track record supporting products that have gained regulatory approvals and recommendations.

Proprietary microbial expression systems, primarily the yeast Hansenula polymorpha and the bacterium E. coli, for recombinant protein production.

Artes competes in the microbial niche of the broader biologics CDMO market. Key competitors include other specialized microbial CDMOs (e.g., Biovian, BIA Separations subsidiaries) and the microbial service divisions of large, diversified CDMOs like Lonza, Sartorius, and Thermo Fisher Scientific. Its differentiation lies in its specific expertise in Hansenula polymorpha and its hybrid service-plus-licensing model.